Thank you SLEAZE BAG Pearson for approaching Allergan in 2014 to make a deal
. Pyott told investors and the market that Pearson was running Valeant as an accounting run up and the numbers didn't add up. Even one of the best hedge funds said the were a short on VRX at the time and that they were an accounting run up. Glad to see this company go down with Pearson at the helm. To bad Allergan had to pay a price for Ackman and Pearson's greed! I'm pretty sure had Allergen been left alone the stock price would be much higher right now.